GRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
GRI Bio Inc is not a strong buy for a beginner, long-term investor at this time. The lack of positive financial performance, absence of significant trading trends, no recent news or catalysts, and neutral technical indicators suggest that this stock does not currently present a compelling investment opportunity.
The MACD is positive but contracting, RSI is neutral at 62.732, and moving averages are converging. The stock is trading near its pivot level of 2.43, with resistance at 2.682 and support at 2.178. No strong bullish or bearish signals are present.
NULL identified. No recent news or significant trading trends.
Poor financial performance with a significant drop in net income (-31.10% YoY) and EPS (-93.98% YoY). No recent insider or hedge fund activity, and no recent congress trading data.
In Q4 2025, revenue remained at 0 with no growth. Net income dropped to -2,659,000 (-31.10% YoY), and EPS fell to -13.25 (-93.98% YoY). Gross margin remained at 0 with no improvement.
No analyst rating or price target changes available.
